EUVIMEDEUVIMED entdecken
Crossref

Neurobehavioral impairments from chromium exposure: Insights from a zebrafish model and drug validation

Seenivasan Boopathi, B Haridevamuthu, Akash Gandhi, S P Ramya Ranjan Nayak, Gokul Sudhakaran, Rajakrishnan Rajagopal, Selvaraj Arokiyaraj, Jesu Arockiaraj

Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · 2024-01 · 275 · 109780

DOI: 10.1016/j.cbpc.2023.109780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2024-01. Verfasst von Seenivasan Boopathi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Katt…. Hauptthemen laut MEDLINE: Chromium, Zebrafish. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have developed a zebrafish model to explore the alterations in neurobehaviors resulting from both acute and chronic exposure to chromium (Cr). Zebrafish exposed to half (HC group: 19.7 mg/L) and a quarter (LC group: 9.85 mg/L) of the LD50 concentration of Cr for a span of 2 weeks exhibited aberrant locomotion, heightened anxiety, cognitive impairment, and reduced aggression - hallmark traits reminiscent of an Alzheimer's Disease (AD)-like syndrome. Furthermore, zebrafish exposed to an environmentally relevant concentration of Cr (EC group: 100 μg/L) for an extended period of 9 weeks exhibited behaviors comparable to those observed in the HC group. Moreover, the study investigated the neuroprotective effects of donepezil (Don), galantamine (Gal) and resveratrol (Res) drugs in response to neurobehavioral impairments induced by Cr (VI) exposure in zebrafish. Don and Res effectively protect the zebrafish from Cr (VI)-induced anxiety, and memory impairment. Furthermore, Cr (VI) exposure induced heightened oxidative stress while simultaneously diminishing antioxidant enzyme levels. Remarkably, these effects were counteracted in the drug-treated groups. Likewise, exposure to Cr (VI) led to an increase in the expression of genes linked to AD and neuroinflammation. Nevertheless, drug treatment reversed this effect in Cr (VI)-exposed fish. The results of our study highlight the potentials of zebrafish model in demonstrating neurobehavioral impairments induced by Cr (VI), thereby paving the way for its utilization in vivo neurobehaviors investigations and pharmaceutical screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChromiumZebrafishAnimalsAntioxidantsOxidative Stress

Stichwörter der Autor:innen

AnxietyChromiumDrug validationMemory impairmentNeurobehavioralOxidative stress

Substanzen

ChromiumAntioxidants

Autor:innen und Institutionen

  • Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur 603203, Chengalpattu District, Tamil Nadu, India. Electroni…
  • Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur 603203, Chengalpattu District, Tamil Nadu, India.
  • Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Food Science & Biotechnology, Sejong University, Seoul 05006, Republic of Korea.

Förderung

  • King Saud University

Zitieren

APA

Boopathi, S., Haridevamuthu, B., Gandhi, A., Nayak, S. P. R. R., Sudhakaran, G., Rajagopal, R., Arokiyaraj, S., & Arockiaraj, J. (2024). Neurobehavioral impairments from chromium exposure: Insights from a zebrafish model and drug validation. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 275, 109780. https://doi.org/10.1016/j.cbpc.2023.109780

Vancouver

Boopathi S, Haridevamuthu B, Gandhi A, Nayak SPRR, Sudhakaran G, Rajagopal R, et al. Neurobehavioral impairments from chromium exposure: Insights from a zebrafish model and drug validation. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2024;275:109780. doi:10.1016/j.cbpc.2023.109780

BibTeX
@article{Boopathi2024,
  author = {Boopathi, Seenivasan and Haridevamuthu, B and Gandhi, Akash and Nayak, S P Ramya Ranjan and Sudhakaran, Gokul and Rajagopal, Rajakrishnan and Arokiyaraj, Selvaraj and Arockiaraj, Jesu},
  title = {Neurobehavioral impairments from chromium exposure: Insights from a zebrafish model and drug validation},
  journal = {Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology},
  year = {2024},
  volume = {275},
  pages = {109780},
  doi = {10.1016/j.cbpc.2023.109780}
}
Kostenlos starten →